Dimeric PKM2 exhibits less PK activity and may be the main form that exists in cancer cells, thereby leading to accumulation of the glycolytic intermediates upstream of PKM2 and further providing a high level of metabolic precursors for synthetic processes. Here, PKM is linked to cancer.